{"title":"Traitement du cancer de l'œsophage","authors":"C. Mariette, J.-P. Triboulet","doi":"10.1016/j.emcchi.2004.06.006","DOIUrl":null,"url":null,"abstract":"<div><p>Surgery, chemotherapy and radiotherapy are the three major arms of the treatment of the oesophagus cancer, and combined modality therapy is required to treat advanced-stage disease. Exclusive chemoradiotherapy is a feasible option for locoregionally advanced-stage disease in responder patients. Elective surgery as a palliative procedure should not be regarded as a standard option in patients with metastatic or non-resectable oesophageal cancer. Surgery appears more and more as an adjuvant therapy in the curative treatment of oesophageal cancer, especially for advanced tumours.</p></div>","PeriodicalId":100414,"journal":{"name":"EMC - Chirurgie","volume":"1 6","pages":"Pages 643-661"},"PeriodicalIF":0.0000,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcchi.2004.06.006","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Chirurgie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762570X04000453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Surgery, chemotherapy and radiotherapy are the three major arms of the treatment of the oesophagus cancer, and combined modality therapy is required to treat advanced-stage disease. Exclusive chemoradiotherapy is a feasible option for locoregionally advanced-stage disease in responder patients. Elective surgery as a palliative procedure should not be regarded as a standard option in patients with metastatic or non-resectable oesophageal cancer. Surgery appears more and more as an adjuvant therapy in the curative treatment of oesophageal cancer, especially for advanced tumours.